[Study on the regulation of autophagy against anticancer drugs' toxicity]

Insights

Autophagy, a key cell process, mediates anticancer drug toxicity in organs like the heart and liver. Understanding this complex role is vital for developing strategies to reduce drug side effects.

Area of Science:

  • Cell Biology
  • Pharmacology
  • Toxicology

Background:

  • Autophagy is a fundamental eukaryotic process regulating cell growth, survival, and metabolism.
  • Autophagy plays a critical role in mediating the toxicity of anticancer drugs, particularly affecting the heart, liver, and neurons.
  • The dual role of autophagy as both protective and detrimental makes its involvement in drug-induced toxicity complex.

Purpose of the Study:

  • To review the concept of autophagy.
  • To summarize the current understanding of autophagy-mediated toxicity induced by anticancer drugs.
  • To highlight the importance of this knowledge for basic research and therapeutic development.

Main Methods:

  • Literature review of scientific articles on autophagy and anticancer drug toxicity.
  • Synthesis of information on the mechanisms of autophagy.
  • Analysis of studies investigating the impact of autophagy on organ-specific toxicity.

Main Results:

  • Autophagy is implicated in the adverse effects of various anticancer agents on vital organs.
  • The intricate mechanisms of autophagy contribute to a complex toxicity profile.
  • Understanding autophagy's role provides insights into differential organ susceptibility.

Conclusions:

  • A comprehensive understanding of autophagy is essential for studying anticancer drug toxicity.
  • Knowledge of autophagy-mediated toxicity can inform strategies to mitigate adverse drug reactions.
  • This review provides a foundation for developing safer and more effective cancer therapies.

Related Concept Videos

Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
6.0K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.9K
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
10.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.1K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.9K